Remove Diabetes Remove Immunization Remove Vaccines
article thumbnail

Chikungunya vaccine approved for select groups by CDC advisory panel

STAT

In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH.

Vaccines 297
article thumbnail

STAT+: Pharmalittle: We’re reading about compounders suing the FDA, Biogen turning to telehealth, and more

STAT

Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list , STAT tells us. A group of doctors and medical practices claimed they overpaid for the vaccine, which was the only mumps shot in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study finds air pollution lowers Covid vaccine response

Express Pharma

People exposed to higher levels of air pollution before the pandemic had lower antibody responses to COVID-19 vaccines, according to a study. The findings, published in the journal Environmental Health Perspectives , provide further evidence on the adverse effects of air pollution on the immune system. Exposure to PM2.5,

Vaccines 110
article thumbnail

How Your Pharmacy Can Participate in American Diabetes Month

Digital Pharmacist

November is American Diabetes Month – a time to come together to spread awareness about diabetes prevention and management. In this blog post, we’ll explore key ways pharmacies can actively participate in American Diabetes Month.

Diabetes 105
article thumbnail

mRNA licensing agreements rise 800% in value as confidence grows beyond vaccines

Express Pharma

Messenger ribonucleic acid (mRNA)-based innovator pharmaceuticals saw a staggering 800 per cent increase in licensing agreement deal values from 2019 to 2024YTD, driven by the remarkable success of mRNA vaccines during the COVID-19 pandemic. billion in 2030. Bristol Myers Squibb formed a multi-year, $1.87

Vaccines 104
article thumbnail

Latest WHO Covid-19 vaccine guidance may decrease future demand

Pharmaceutical Technology

The World Health Organisation (WHO) has revised its recommendations regarding the use of Covid-19 vaccines following a meeting of the agency’s Strategic Advisory Group of Experts on Immunisation (SAGE). The panel emphasised that the extra booster dose recommendation only pertains to one shot and is not for continued annual booster vaccines.

Vaccines 111
article thumbnail

GSK launches shingles vaccine, Shingrix in India

Express Pharma

GlaxoSmithKline Pharmaceuticals (GSK) announced the launch of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) in India, for the prevention of shingles (herpes zoster) and post-herpetic neuralgia in adults aged 50 years and above. Shingrix is a non-live, recombinant subunit vaccine to be given intramuscularly in two doses.